Vowst's FDA approval is a boon for the prevention of recurrent Clostridioides difficile infection
- PMID: 38098563
- PMCID: PMC10718391
- DOI: 10.1097/MS9.0000000000001410
Vowst's FDA approval is a boon for the prevention of recurrent Clostridioides difficile infection
Conflict of interest statement
The authors do not have any conflicts of interest to declare.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
References
-
- Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015;372:1539–1548. - PubMed
-
- Crobach MJT, Planche T, Eckert C, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 2016;22(suppl 4):S63–S81. - PubMed
Publication types
LinkOut - more resources
Full Text Sources